These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 22131389)

  • 1. Monitoring of ovarian activity by measurement of urinary excretion rates of estrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part II: reliability of home testing.
    Blackwell LF; Vigil P; Gross B; d'Arcangues C; Cooke DG; Brown JB
    Hum Reprod; 2012 Feb; 27(2):550-7. PubMed ID: 22131389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
    Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
    Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of ovarian activity by measurement of urinary excretion rates using the Ovarian Monitor, Part IV: the relationship of the pregnanediol glucuronide threshold to basal body temperature and cervical mucus as markers for the beginning of the post-ovulatory infertile period.
    Blackwell LF; Vigil P; Alliende ME; Brown S; Festin M; Cooke DG
    Hum Reprod; 2016 Feb; 31(2):445-53. PubMed ID: 26677961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal monitoring of ovarian activity using the Ovarian Monitor, part I. Validation of home and laboratory results obtained during ovulatory cycles by comparison with radioimmunoassay.
    Blackwell LF; Brown JB; Vigil P; Gross B; Sufi S; d'Arcangues C
    Steroids; 2003 May; 68(5):465-76. PubMed ID: 12798498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prediction and/or detection of ovulation by means of urinary steroid assays.
    Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E
    Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring the menstrual cycle: Comparison of urinary and serum reproductive hormones referenced to true ovulation.
    Roos J; Johnson S; Weddell S; Godehardt E; Schiffner J; Freundl G; Gnoth C
    Eur J Contracept Reprod Health Care; 2015; 20(6):438-50. PubMed ID: 26018113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The validation of the Billings ovulation method by laboratory research and field trials.
    Billings JJ
    Acta Eur Fertil; 1991; 22(1):9-15. PubMed ID: 1746210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of ovarian follicle size and the urinary excretion of oestrone glucuronide, luteinizing hormone and pregnanediol glucuronide in spontaneous cycles.
    Adekunle AO; Collins WP; Whitehead MI
    Afr J Med Med Sci; 1988 Jun; 17(2):77-82. PubMed ID: 2843021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the Home Ovarian Monitor in pregnancy avoidance.
    Brown JB; Holmes J; Barker G
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2008-11. PubMed ID: 1755460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
    Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP
    Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective multicentre study to develop universal immunochemical tests for predicting the fertile period in women. World Health Organisation Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
    Int J Fertil; 1985; 30(3):18-30. PubMed ID: 2867054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring the menstrual cycle of humans and lowland gorillas based on urinary profiles of bioactive follicle-stimulating hormone and steroid metabolites.
    Dahl KD; Czekala NM; Lim P; Hsueh AJ
    J Clin Endocrinol Metab; 1987 Mar; 64(3):486-93. PubMed ID: 3102537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of ovulation by low-dose mifepristone (RU 486).
    Ledger WL; Sweeting VM; Hillier H; Baird DT
    Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting menstrual migraine with a home-use fertility monitor.
    MacGregor EA; Frith A; Ellis J; Aspinall L
    Neurology; 2005 Feb; 64(3):561-3. PubMed ID: 15699399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of subtle and severe menstrual disturbances in exercising women: confirmation using daily hormone measures.
    De Souza MJ; Toombs RJ; Scheid JL; O'Donnell E; West SL; Williams NI
    Hum Reprod; 2010 Feb; 25(2):491-503. PubMed ID: 19945961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the time of ovulation in chimpanzees by measurement of LH, estrone sulfate, and pregnanediol 3 alpha-glucuronide in urine: comparison with serum hormone patterns.
    Steinetz BG; Ducrot C; Randolph C; Mahoney CJ
    J Med Primatol; 1992 Jul; 21(5):239-45. PubMed ID: 1404332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between indicators of the fertile period of the menstrual cycle and ultrasonically-determined ovulation].
    Croce P; Quarenghi A; Montanari G; Barbato M; Pravettoni G; Bertolotti G
    Minerva Endocrinol; 1989; 14(3):147-52. PubMed ID: 2622425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct assay of urinary steroid glucuronides for monitoring the approach of ovulation.
    Merlo AB; Farinati Z; Quiroga S; Nagle CA; Carril LM; Lahoz M; Mendizabal AF
    Int J Fertil; 1984; 29(3):189-93. PubMed ID: 6152260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring ovarian cycle activity via progestagens in urine and feces of female mountain gorillas: A comparison of EIA and LC-MS measurements.
    Habumuremyi S; Robbins MM; Fawcett KA; Deschner T
    Am J Primatol; 2014 Feb; 76(2):180-91. PubMed ID: 24123105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary progesterone and pregnanediol. Use for monitoring progesterone treatment.
    Stanczyk FZ; Gentzschein E; Ary BA; Kojima T; Ziogas A; Lobo RA
    J Reprod Med; 1997 Apr; 42(4):216-22. PubMed ID: 9131494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.